Delivery Order SPE2DB25D3504-SPE2DB25FVWEB
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order from the Defense Logistics Agency valued at $1,654.33 for ProQuad vials. This competitively awarded, firm fixed-price contract has an ultimate completion date of September 5, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a competitively awarded delivery order from the Defense Logistics Agency valued at $1,687.48 for ProQuad vials. This contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999 through December 2026. The award was issued on August 19, 2025, with an ultimate completion date of...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $5,480.80 by the Defense Logistics Agency for the supply of ProQuad vials. The contract was competitively awarded on September 18, 2025, with an ultimate completion date of October 9, 2025. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order represents a firm fixed-price contract with no set-aside designation, indicating open competition among qualified vendors. This...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,687.48 by the Defense Logistics Agency (DLA) on September 25, 2025, for the supply of ProQuad vials with an ultimate completion date of October 17, 2025. The contract is competitively awarded with no set-aside designation and utilizes firm fixed-price pricing. Performance will take place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $1,670.90 to AmerisourceBergen Drug Corp for ProQuad vials, with an ultimate completion date of August 18, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $8,437.20 by the Defense Logistics Agency on September 2, 2025, for the supply of ProQuad vials with a completion date of September 23, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded to the pharmaceutical distributor's Corporate Office division. The place of performance is AmerisourceBergen's headquarters in Conshohocken, Pennsylvania. This delivery order operates under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order for ProQuad vials valued at $6,683.60 by the Defense Logistics Agency (DLA). The contract, awarded on July 21, 2025, with an ultimate completion date of August 11, 2025, represents a firm fixed-price delivery order with no set-aside designation. This award is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,341.80 by the Defense Logistics Agency on June 18, 2025, for the supply of ProQuad vials. The award is a non-set-aside, firm fixed price delivery order with an ultimate completion date of July 11, 2025. This delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,687.48 by the Defense Logistics Agency on September 11, 2025, for the supply of ProQuad vials. This non-competitive, firm fixed-price delivery order is expected to be completed by October 2, 2025, with performance taking place at the vendor's Conshohocken facility. The award represents a child contract issued under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,740.49 by the Defense Logistics Agency on September 8, 2025, with an ultimate completion date of September 29, 2025. The delivery order, identified as 4569422407, is for Proquad vials and is structured as a firm fixed price, non-set-aside contract. This award represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DB25D3504Indefinite Delivery Contract
- SPE2DB25D3504-SPE2DB25FVWEBDelivery Order
AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,670.90 by the Defense Logistics Agency for ProQuad vials, with an ultimate completion date of September 23, 2025. The contract employs firm fixed-price pricing and was awarded on a competitive basis without set-aside restrictions. Performance will take place at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. The company's federal contract portfolio encompasses a broad range of pharmaceutical products and medical supplies, including vaccines, specialty medications, generic and brand-name drugs, and medical devices across multiple therapeutic domains. As a major contractor supporting defense health requirements, AmerisourceBergen maintains the capability to fulfill diverse federal medical supply needs through competitive procurement processes, and the company is positioned to potentially participate in the Defense Logistics Agency's planned Pharmaceutical Prime Vendor Global Program Generation V contracts, which are expected to involve multiple regional awards.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 9/2/25 |